Vitamin D receptor polymorphisms and pro
✍
Dan G. Blazer III; David M. Umbach; Roberd M. Bostick; Jack A. Taylor
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 98 KB
Prostate cancer is a common disease, yet determinants of prostate cancer risk remain largely unidentified. Low circulating levels of 1,25-dihydroxy vitamin D (1,25-D) have been implicated as a risk factor for prostate cancer. In addition, 1,25-D exhibits significant antineoplastic properties both in